Discontinuation report JEVTANA
| Report ID | 196086 |
| Drug Identification Number | 02369524 |
| Brand name | JEVTANA |
| Common or Proper name | JEVTANA |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CABAZITAXEL |
| Strength(s) | 40MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1 |
| ATC code | L01CD |
| ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
| Reason for discontinuation | Other (Please describe in comments) |
| Anticipated discontinuation date | 2023-10-31 |
| Actual discontinuation date | 2023-09-11 |
| Remaining supply date | |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | All available inventory has been consumed and has been officially discontinued. |
| Company comments | Patent end December 2019, Generic is available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-09-13 | English | Compare |
| v3 | 2023-06-21 | French | Compare |
| v2 | 2023-06-21 | English | Compare |
| v1 | 2023-06-21 | English | Compare |
Showing 1 to 4 of 4